DARZALEX (Daratumumab)

**Product type:** Human Prescription Drug

**Active ingredient:** DARATUMUMAB

**Strength:** 100 mg/5mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Janssen Biotech, Inc.

**Marketing category:** BLA (BLA761036)

**Pharmacologic class:** Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]